Invasion of the mineralized matrix by endothelial cells and osteoclasts is a key event in endochondral bone formation. To examine the putative role of osteoclast activity in the angiogenic process, we used two in vivo models of suppressed
bone resorption: mice treated with the
bisphosphonate clodronate and in osteoclast-deficient, osteopetrotic mice. Angiogenesis was assessed in caudal vertebrae of these neonatal mice. This model enables us to study the interaction between osteoclasts and endothelial cells during endochondral bone formation. In control conditions, sinusoid-like structures were detected in the vicinity of
tartrate resistance
acid phosphatase positive (
TRAcP+) osteoclasts. Treatment with
clodronate completely abolished osteoclastic
bone resorption, whereas angiogenesis remained unaffected. In line with these observations, in the osteopetrotic mouse mutants c-fos knockout mice and op/op mice, capillaries invaded the calcified cartilage in the absence of osteoclasts. In conclusion, our data strongly suggest that during endochondral bone formation, vascular invasion can occur in the absence of osteo(chondro)clastic resorption. In addition,
bisphosphonates show no apparent effect on angiogenesis in this in vivo model. These findings may have important clinical implications in the management of skeletal disorders such as metastatic
bone disease, in which both osteoclastic
bone resorption and angiogenesis contribute to
tumor growth. On the other hand, our results confirm that
bisphosphonates can be used safely in the treatment of disorders that affect the growing skeleton, such as in
juvenile osteoporosis.